Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood

Department of Pediatrics, Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland.
Archives of general psychiatry (Impact Factor: 13.75). 08/2010; 67(8):841-9. DOI: 10.1001/archgenpsychiatry.2010.92
Source: PubMed

ABSTRACT Prenatal smoking exposure modulates brain development, which may deviate mental development of the offspring.
To study the effects of prenatal smoking exposure on psychiatric morbidity and mortality among Finnish young adults by means of population-based longitudinal register data.
Information on maternal smoking as reported by the mothers (0, <10, or >10 cigarettes a day) and other background factors (maternal age and parity and child's sex, gestational age, birth weight, and 5-minute Apgar score) was derived from the Finnish Medical Birth Register. Information on children's psychiatric diagnoses related to outpatient visits (1998-2007), children's inpatient care (1987-2007), and mothers' psychiatric inpatient care (1969-1989) was derived from the Finnish Hospital Discharge Register. Information on deaths and their causes for the children (1987-2007) was received from the Cause-of-Death Register.
Population-based study of all singletons born in Finland from 1987 to 1989 with information on prenatal smoking exposure. Patients The source population included all singleton births in Finland from January 1, 1987, through December 31, 1989 (n = 175 869), excluding children with major congenital anomalies (3.1%) and children who died during the first week of life (0.3%).
Psychiatric morbidity and mortality.
The prevalence of maternal smoking was 15.3%. The risk of psychiatric morbidity was significantly higher in the exposed children than in the unexposed children. Among the offspring of mothers who smoked fewer than 10 cigarettes a day, 21.0% had any psychiatric diagnoses (adjusted odds ratio [OR], 1.53 [95% confidence interval (CI), 1.47-1.60]) compared with 24.7% among those of mothers who smoked more than 10 cigarettes a day (1.85 [1.74-1.96]) and 13.7% in the unexposed children (the reference group). The risk was significantly increased for most of the psychiatric diagnoses. The strongest effects were in psychiatric disorders due to psychoactive substance use and in behavioral and emotional disorders. The risk of mortality was significantly higher in children exposed to more than 10 cigarettes a day (OR, 1.69 [95% CI, 1.31-2.19]) compared with unexposed children.
Prenatal smoking exposure is associated with an increased risk of psychiatric morbidity, whereas prenatal exposure to more than 10 cigarettes a day increases the risk of mortality in childhood, adolescence, and young adulthood.

Download full-text


Available from: Jyrki Korkeila, Aug 02, 2015
  • Source
    • "Although these initial results require replication, there appears to be an association between PEMS and greater hallucination severity at initial hospitalization for FEP. This is consistent with limited prior studies indicating that PEMS may elevate risk for psychotic symptoms/disorders (Spauwen et al., 2004; Zammit et al., 2009; Ekblad et al., 2010). We found a lower severity of deficit symptoms, which is inconsistent with the prior report indicating that PEMS was associated with greater negative symptom severity (Stathopoulou et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prenatal exposure to maternal smoking (PEMS) has been linked to diverse negative perinatal outcomes (Cnattingius, 2004) and far- reaching neurobehavioral consequences, including impaired cognition, attention-deficit/hyperactivity disorder, and conduct disorder (Cornelius and Day, 2009; Gaysina et al., 2013). Although one study did not demon- strate a link between PEMS and risk for schizophrenia (Baguelin-Pinaud et al., 2010), Stathopoulou et al. (2013) found that prenatal tobacco expo- sure was independently associated with a later schizophrenia diagnosis.
    Schizophrenia Research 05/2015; 164(1-3):277-278. DOI:10.1016/j.schres.2015.02.012 · 4.43 Impact Factor
  • Source
    • "This design allows assessment of the influence of the mood disorder on the health of the offspring. In the same vein, many early studies have not controlled for the influence of alcohol use and smoking with their independent adverse effects (Ekblad et al., 2010). Nonetheless, a good number of clinical studies and population based case-control studies have controlled for these factors. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The paper by Robinson posits that risks from prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants are not different from the risks encountered in the general population and that untoward effects of SSRIs are difficult to distinguish from those of the mood disorder. Indeed, maternal depression and anxiety can have negative consequences for fetal and postnatal development. Fortunately, experimental evidence suggests that mood and anxiety disorder symptoms often respond to psychosocial interventions. If pharmacotherapy becomes necessary, it is, however, important to know that even if SSRI drugs have been shown to be safe overall, research has shown that fetal development can be adversely affected by in utero exposure to SSRIs in a subgroup of neonates. Examples would be the transient neonatal adaptation syndrome, an increased risk of persistent pulmonary hypertension of the newborn, and small, albeit measurable, changes in motor and social adaptability in infancy and childhood.
    Journal of Nervous & Mental Disease 03/2015; 203(3):167-9. DOI:10.1097/NMD.0000000000000258 · 1.81 Impact Factor
  • Source
    • "One previous study has investigated the association specifically for BPD and showed an increased risk (Talati et al., 2013). Another study showed it to be associated with an increased risk of mood disorders (Ekblad et al., 2010), while two studies did not find any association with anxiety or major depression (Fergusson et al., 1998; Weissman et al., 1999). Based on the inconsistent findings on mood disorders, and only one previous published study on BPD, we aim to examine the association between maternal smoking during pregnancy and the risk of BPD, in this large nationwide population based epidemiological study. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prenatal smoking exposure affects fetal growth and development and is associated with increased risk of various neurodevelopmental disorders. Only one previous study has examined the association between maternal smoking during pregnancy and the risk of bipolar disorder (BPD).
    Journal of Affective Disorders 09/2014; 171C:132-136. DOI:10.1016/j.jad.2014.09.030 · 3.71 Impact Factor
Show more